PubMed

A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis.

Fendrick AM, Greenberg BP.

Osteopath Med Prim Care. 2009 Jan 6;3:1.PMID: 19126235 [PubMed - in process]Related articlesFree article

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.PMID: 18405470 [PubMed - indexed for MEDLINE]Related articlesFree article

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):481-96. Epub 2008 Nov 27.PMID: 19053986 [PubMed - indexed for MEDLINE]Related articles

The role of rofecoxib, a cyclooxygenase-2-specific inhibitor, for the treatment of non-cancer pain: a review.

Fine PG; Department of Anesthesiology, School of Medicine, University of Utah, Salt Lake City, 84108, USA. fine@aros.net.

J Pain. 2002 Aug;3(4):272-83.PMID: 14622751 [PubMed]Related articles

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.

Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG; National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group.

BMJ. 2009 Jul 14;339:b2538. doi: 10.1136/bmj.b2538.PMID: 19602530 [PubMed - indexed for MEDLINE]Related articlesFree article

Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):223-7.PMID: 18084859 [PubMed - indexed for MEDLINE]Related articles

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.

Rahme E, Nedjar H.

Rheumatology (Oxford). 2007 Mar;46(3):435-8. Epub 2007 Jan 25.PMID: 17255138 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.

Dajani EZ, Islam K.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:117-33. Review.PMID: 18812633 [PubMed - indexed for MEDLINE]Related articlesFree article

The David Y. Graham lecture: use of nonsteroidal antiinflammatory drugs in a COX-2 restricted environment.

Chan FK.

Am J Gastroenterol. 2008 Jan;103(1):221-7. Epub 2007 Sep 25.PMID: 17900323 [PubMed - indexed for MEDLINE]Related articles

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Chan FK, Abraham NS, Scheiman JM, Laine L; First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Am J Gastroenterol. 2008 Nov;103(11):2908-18. Epub 2008 Oct 1.PMID: 18853980 [PubMed - indexed for MEDLINE]Related articles

Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review.

Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW.

Spine (Phila Pa 1976). 2008 Jul 15;33(16):1766-74. Review.PMID: 18580547 [PubMed - indexed for MEDLINE]Related articles

COX-2 selective inhibitors in the treatment of osteoarthritis.

Laine L, White WB, Rostom A, Hochberg M.

Semin Arthritis Rheum. 2008 Dec;38(3):165-87. Epub 2008 Jan 4. Review.PMID: 18177922 [PubMed - indexed for MEDLINE]Related articles

What a difference a year makes: reflections on the ACR recommendations for the medical management of osteoarthritis.

Hochberg MC.

Curr Rheumatol Rep. 2001 Dec;3(6):473-8. Review.PMID: 11709108 [PubMed - indexed for MEDLINE]Related articles

Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention.

Vonkeman HE, van de Laar MA.

Semin Arthritis Rheum. 2010 Feb;39(4):294-312. Epub 2008 Sep 27.PMID: 18823646 [PubMed - in process]Related articles

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.

Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay CL, Ruland S, Mellein B, Matchaba PT, Fuster V, Abramson SB.

Ann Rheum Dis. 2007 Jun;66(6):764-70. Epub 2007 Apr 5.PMID: 17412741 [PubMed - indexed for MEDLINE]Related articles

The role of analgesics in the management of osteoarthritis pain.

Brandt KD.

Am J Ther. 2000 Mar;7(2):75-90. Review.PMID: 11319576 [PubMed - indexed for MEDLINE]Related articles

Prevention of NSAID-Induced Ulcers.

Scheiman JM.

Curr Treat Options Gastroenterol. 2008 Mar;11(2):125-34.PMID: 18321440 [PubMed - in process]Related articles

Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection.

Gaziano JM, Gibson CM.

Am J Cardiol. 2006 May 8;97(9A):23-9. Epub 2006 Mar 30. Review.PMID: 16675319 [PubMed - indexed for MEDLINE]Related articles

Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.

Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. Epub 2008 Aug 22.PMID: 18729848 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.

Joshi GP, Gertler R, Fricker R.

Anesth Analg. 2007 Dec;105(6):1793-804, table of contents. Review.PMID: 18042885 [PubMed - indexed for MEDLINE]Related articles